Sutro Biopharma (STRO) Tax Provisions (2022 - 2026)
Sutro Biopharma (STRO) posted Tax Provisions of -$88000.0 for Q4 2025, down 388.89% sequentially from -$18000.0 in Q2 2025, and down 103.74% YoY from $2.4 million in Q4 2024.
Sutro Biopharma (STRO) Tax Provisions (2022 - 2026) Analysis & Trends
Sutro Biopharma has reported Tax Provisions for 4 years, with the latest figure at -$88000.0 in Q4 2025.
- Quarterly Tax Provisions fell 103.74% year-over-year to -$88000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (down 87.63% YoY) and the FY2025 annual result came in at -$99000.0, down 104.19% from the prior year.
- Tax Provisions slipped to -$88000.0 in Q4 2025 per STRO's latest filing, from -$18000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $15.8 million in Q4 2023 and troughed at -$88000.0 in Q4 2025.
- A 4-year average of $2.6 million and a median of $395000.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions tumbled 85.11% in 2024, then slumped 325.0% in 2025.
- Over 4 years, Tax Provisions stood at $2.5 million in 2022, then jumped by 532.6% to $15.8 million in 2023, then sank by 85.11% to $2.4 million in 2024, then plunged by 103.74% to -$88000.0 in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered -$88000.0, -$18000.0, and $2.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Dec 31, 2025 | -88,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Dec 31, 2024 | 2.36 Mn |
| Jun 30, 2024 | 8,000.00 |
| Dec 31, 2023 | 15.82 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 151,000.00 |
| Mar 31, 2023 | 395,000.00 |
| Jun 30, 2022 | 2.50 Mn |